El Paso, TX – The Medical Center of the Americas Foundation (MCA) announced a monthly speakers series featuring representatives from globally recognized government (NIH) and industry biopharma and MedTech organizations looking to advance new clinical medical innovation forward. Participants include representatives from local and national academic institutions, healthcare systems and clinics, clinical research sites, and life science service organizations. The “CTx Briefings” event series begins virtually on March 3, 2022, at 1:00 PM (MST).
The CTx Briefings will feature Lorena Kuri, Head of Diversity & Strategy with Bristol Myers Squibb, a global pharmaceutical company. Lorena will be speaking about Clinical Trial Diversity and Inclusion, why it’s important, and what is being done globally to increase clinical trial access particularly for underrepresented groups including lower socioeconomic and vulnerable populations.
The purpose of the series is to foster learning about the latest healthcare innovations underway, drive clinical trial opportunities to our region, and provide an ongoing mechanism to facilitate the continued communication, growth, and success of our region’s clinical research network. “It is gratifying to finally offer this speaker series, which started initially as a COVID Clinical Trial Pipeline Taskforce, to a broader audience with an expanded scope that now includes all medical specialties on behalf our region’s growing biomedical ecosystem, says Michaele Linden-Johnson, Director of Clinical Trials & Business Development. “I can already see the impact this type of programming is having and suspect this meeting series will continue to spur innovation, networking, and business opportunities locally and nationally.”
For more information about the CTx Briefings event series or to sign up for the first installment of the event series, visit the Medical Center of the Americas Foundation website at https://mcamericas.org/clinical-trials.